5, 6-RING ANNULATED INDOLE DERIVATIVES AND USE THEREOF
申请人:Bennett Frank
公开号:US20100322901A1
公开(公告)日:2010-12-23
The present invention relates to 5,6-ring annulated indole derivatives of the formula (I), compositions comprising at least one 5,6-ring annulated indole derivatives, and methods of using the 5,6-ring annulated indole derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
Discovery of aryl aminothiazole γ-secretase modulators with novel effects on amyloid β-peptide production
作者:Sanjay Bhattarai、Lei Liu、Michael S. Wolfe
DOI:10.1016/j.bmcl.2021.128446
日期:2021.12
A series of analogs based on a prototype aryl aminothiazole γ-secretase modulator (GSM) were synthesized and tested for their effects on the profile of 37-to-42-residue amyloid β-peptides (Aβ), generated through processive proteolysis of precursor protein substrate by γ-secretase. Certain substitutions on the terminal aryl D ring resulted in an altered profile of Aβ production compared to that seen
TRICYCLIC INDOLE DERIVATIVES AND METHODS OF USE THEREOF
申请人:Venkatraman Srikanth
公开号:US20110189127A1
公开(公告)日:2011-08-04
The present invention relates to Tricyclic Indole Derivatives, compositions comprising at least one Tricyclic Indole Derivatives, and methods of using the Tricyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF
申请人:Anikumar Gopinadhan N.
公开号:US20110104110A1
公开(公告)日:2011-05-05
The present invention relates to Substituted Indole Derivatives, compositions comprising at least one Substituted Indole Derivative, and methods of using these Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
TETRACYCLIC INDOLE DERIVATIVES AND THEIR USE FOR TREATING OR PREVENTING VIRAL INFECTIONS
申请人:Bennett Frank
公开号:US20110104109A1
公开(公告)日:2011-05-05
The present invention relates to Tetracyclic Indole Derivatives, compositions comprising at least one Tetracyclic Indole Derivative, and methods of using the Tetracyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.